Apollo Life Sciences Produces New Range Of Human Cell Protein Detection Kits

Sydney, Australia - Apollo Life Sciences announced that it has produced a new range of protein detection kits for the scientific research market. These kits incorporate proteins expressed exclusively from human cells.

Protein detection kits are used in scientific research and medical diagnosis to measure protein quantity in a sample, as a basis for developing understanding of diseases and evaluating effectiveness of treatments and dosages.

Apollo's new protein detection kits measure human cell-expressed proteins up to ten times more accurately than kits already available in the market, which traditionally use bacteria, insect or rodent cells. "Because they will measure human samples more accurately, there is a potentially large impact on medical diagnostics and research of new treatments," said John Priest, Apollo's Chairman and Chief Executive Officer.

Apollo has developed a unique range of kits to measure ten different proteins. "Apollo's human cell-expressed proteins ! more closely resemble the structure of natural proteins already found in human blood," said Dr Alan Watts, Apollo's Science Director. "The antibodies which perform the detection role in the kits recognise Apollo's proteins differently from competitor products, which are generally derived from bacteria or rodent cells."

The global market for protein detection systems is estimated to be worth US$8.5 billion per year. "We anticipate Apollo's protein detection kits will become the preferred product for scientists because the kits provide greater accuracy in the measurement of a range of proteins," said John Priest. For example, clinical scientists use protein detection kits to measure the amount of EPO (erythropoietin) in the blood of humans. EPO is a hormone that enables the body to increase red blood cell production. Measuring EPO can be crucial to understanding the mechanism of diseases, and lead to new treatments.

Apollo launched the first of its te! n detection kits into the worldwide R&D reagents market this week, alo ng with its sister product range of 50 human-expressed proteins. Both the human-expressed protein range and kits can be purchased directly from the company's website www.apollocytokineresearch.com.

With the addition of more kits to the product range in the first half of 2006, Apollo expects to capture a significant share of the protein detection market. Its human-expressed protein products are unique.

SOURCE: Apollo Life Sciences